Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-002304-41Phase 4Completed
Phase 4, randomised trial of risperidone in schizophrenia and schizoaffective disorder (2 arms), sponsored by Janssen Pharmaceutical. Started Jul 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-002304-41.